课题基金 / 基金详情

CORE--CELL AND ISLET ISOLATION CORE

CORE--CELL AND ISLET ISOLATION CORE
核心--细胞和胰岛隔离核心
批准号:
7550805
负责人:
JERRY L. NADLER
金额:
$17.76万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-02-01 至 2008-01-31

项目摘要

项目成果

JERRY L. NADLER的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The proposed Cell and Islet Isolation Core (CIIC) will be comprised of two laboratories: a cell and islet isolation laboratory (CIL) and islet function laboratory (IFL). The four general goals for the CIIC are: A) to isolate adipocytes, selected muscles and pancreatic islets from experimental animals, including rats, mice and pigs, for DERC members in an economical and high quality manner; B) to provide, standardize and develop assessments of islet function for the DERC members, C) to provide, in a cost efficient manner, culture media, fetal calf serum and cell culture and storage facilities for DERC members; and D) to encourage collaborative research activities among DERC investigators utilizing the resources of the CIIC core. DERC investigators frequently need freshly isolated preparations of insulin target tissues and pancreatic islets to test the impact of genetic, pharmacologic, nutritional or behavioral interventions. However, when this usage is intermittent and dictated by individual research projects, laboratories cannot maintain the technical expertise or equipment to isolate these tissues and cells. This is particularly an issue for islet tissue. The CIL will isolate cells and islets. Dr. Zandong Yang has extensive experience in methods for isolating islets and in the study of islet function. He and Dr. Nadler will provide overall direction to this Core. This Cell and Islet isolation lab will interact closely with Dr. Keller (Animal Characterization Core Director) both for the conduct of specific assays as well (insulin, c-peptide) as for additional technical expertise for muscle and adipocyte isolation. The CIIC will provide high-quality cells, muscles and islets in a timely manner using fully equipped facility to meet the demands of these studies. Dr. Yang with Dr. Meng Chen will direct the IFL, with oversight by Dr. J. Nadler. The goal of this lab is to assess islet function in a standardized and cost-efficient manner. The IFL will assess function of islets that are isolated by the CIL, and also analyze beta cells and beta-1ike cells (such as stem cells or other cells differentiated for insulin secretory function). This lab will perform A) kinetic studies in islets and beta cells: static insulin secretion and islet perifusion; (B) immunohistochemical studies of islets, including insulin, glucagon; apoptosis detection in islets and beta cells; and an image documentation service.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of the Interleukin12/STAT4 Pathway in Insulin Resistance and Atherosclerosis
  • 批准号:
    8258687
  • 项目类别:
  • 资助金额:
    $36.63万
  • 财政年份:
    2011
  • 负责人:
    JERRY L. NADLER
  • 依托单位:
Role of the Interleukin12/STAT4 Pathway in Insulin Resistance and Atherosclerosis
  • 批准号:
    8587826
  • 项目类别:
  • 资助金额:
    $4.4万
  • 财政年份:
    2011
  • 负责人:
    JERRY L. NADLER
  • 依托单位:
Role of the Interleukin12/STAT4 Pathway in Insulin Resistance and Atherosclerosis
  • 批准号:
    8585090
  • 项目类别:
  • 资助金额:
    $40.2万
  • 财政年份:
    2011
  • 负责人:
    JERRY L. NADLER
  • 依托单位:
Role of the Interleukin12/STAT4 Pathway in Insulin Resistance and Atherosclerosis
  • 批准号:
    8764735
  • 项目类别:
  • 资助金额:
    $40.4万
  • 财政年份:
    2011
  • 负责人:
    JERRY L. NADLER
  • 依托单位:
国内基金
海外基金
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
  • 批准号:
    LBY21H010001
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2020
  • 负责人:
    郑绪阳
  • 依托单位:
去乙酰化酶SIRT1在前体mRNA可变剪切中的作用及其生理病理效应研究
  • 批准号:
    31970691
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2019
  • 负责人:
    张胜萍
  • 依托单位:
TM9SF4调控非小细胞肺癌细胞凋亡机制研究
  • 批准号:
    31900527
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    24.0万元
  • 批准年份:
    2019
  • 负责人:
    孙磊
  • 依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
  • 批准号:
    81703335
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2017
  • 负责人:
    卫高菲
  • 依托单位: